{"id":903725,"date":"2025-10-31T12:02:36","date_gmt":"2025-10-31T16:02:36","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately\/"},"modified":"2025-10-31T12:02:36","modified_gmt":"2025-10-31T16:02:36","slug":"shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately\/","title":{"rendered":"Shareholders who lost money in shares of DexCom, Inc. (NASDAQ: DXCM) Should Contact Wolf Haldenstein Immediately"},"content":{"rendered":"<h2>\nLead Plaintiff Deadline is December 26, 2025<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p align=\"justify\">NEW YORK, Oct.  31, 2025  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=pkXjy8GlMNzVQmiQuizyUhlIaCrbsbyfCPhNPA7I91DvlSae3uS4oHeqSqiht1BMD6F7Dw5Myrj-aPYkATSLHfbblMNFY8aPLDrxXKZPWa83dH2JFE5WffyTEXIVBYmy7q5DaR8MSChYgKMjA4Oj3q8Qlxse_hwMNnYrqof5qCY=\" rel=\"nofollow\" target=\"_blank\">Wolf Haldenstein Adler Freeman &amp; Herz LLP<\/a> reminds investors that a federal securities class action lawsuit has been filed against <strong>DexCom, Inc.<\/strong> (\u201cDexCom\u201d or the \u201cCompany\u201d) (NASDAQ: DXCM) and certain of its officers for alleged violations of federal securities laws.<\/p>\n<p align=\"center\">\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=tliex7f_CZ9vJC6TcvKSsSkGtR2iDt1IRRK4cn7Ofe2dvexSU5hR8tRCy6mtwzoocgjlLGuDClUaumH1vKsfxozPEKvK3n4nL4FCHv8EsIMZP0IKCg-UuNA0qUHSlD2OClaw6dgLXgAsLXn8RrbXJ1ZYKh4ztoau6ogN-eLt7IePCFRt9GjHf30iHfMp7v8N\" rel=\"nofollow\" target=\"_blank\"><br \/>\n          <strong>PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION<\/strong><br \/>\n        <\/a>\n      <\/p>\n<p align=\"justify\">\n        <strong>Class Period:<\/strong> July 26, 2024 \u2013 September 17, 2025 (inclusive)<\/p>\n<p align=\"justify\">The complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements and failed to disclose that:<\/p>\n<ol style=\"list-style-type:decimal\">\n<li style=\"margin-bottom:8pt;text-align:justify\">DexCom made material design changes to its G6 and G7 continuous glucose monitoring devices without authorization from the U.S. Food and Drug Administration (FDA)<\/li>\n<li style=\"margin-bottom:8pt;text-align:justify\">These unauthorized changes made the devices less reliable and posed health risks to users;<\/li>\n<li style=\"margin-bottom:8pt;text-align:justify\">The Company overstated the reliability, accuracy and functionality of the G7 device;<\/li>\n<li style=\"margin-bottom:8pt;text-align:justify\">DexCom downplayed the scope and severity of these issues; and<\/li>\n<li style=\"margin-bottom:8pt;text-align:justify\">The Company faced increased risks of regulatory scrutiny, enforcement action and financial harm.<\/li>\n<\/ol>\n<p align=\"justify\">\n        <strong>Key Events:<\/strong>\n      <\/p>\n<ul type=\"disc\">\n<li style=\"text-align:justify\">March 10, 2025 \u2013 FDA Warning Letter:<\/li>\n<\/ul>\n<p align=\"justify\">The FDA issued a Warning Letter stating that DexCom had\u00a0<em>\u201cadulterated\u201d<\/em> its G6 and G7 sensors by modifying them without prior approval, resulting in larger inaccuracies and increased health risks for users. <strong>Stock dropped $7.12 (\u22129.15%) to $70.72<\/strong>.<\/p>\n<ul type=\"disc\">\n<li style=\"text-align:justify\">March 25\u201326, 2025 \u2013 Public Disclosure:<\/li>\n<\/ul>\n<p align=\"justify\">The FDA published the Warning Letter on its website, further confirming the product issues<strong>. Stock fell another $3.19 (\u22124.24%) to $72.13.<\/strong><\/p>\n<ul type=\"disc\">\n<li style=\"text-align:justify\">September 8, 2025 \u2013 Oppenheimer Downgrade:<\/li>\n<\/ul>\n<p align=\"justify\">Oppenheimer downgraded DexCom to \u201cperform\u201d from \u201coutperform\u201d, citing rising patient concerns over G7 sensor accuracy issues, failed insertions, and abrupt stoppages. Stock\u00a0<strong>declined $2.51 (\u22123.12%) to $78.00.<\/strong><\/p>\n<ul type=\"disc\">\n<li style=\"text-align:justify\">September 18, 2025 \u2013 Hunterbrook Report:<\/li>\n<\/ul>\n<p align=\"justify\">Hunterbrook Research published a report titled\u00a0<em>\u201cDexCom\u2019s Fatal Flaws,\u201d <\/em>revealing through FDA records and interviews that G7 devices had caused hospitalizations and deaths due to inaccurate readings. The report accused DexCom of cutting<strong> corners to <\/strong>protect margins. <strong>Stock plunged $8.99 (\u221211.76%) over two sessions to $67.45.<\/strong><\/p>\n<p>\n        <strong>What Are The Next Steps:<\/strong><br \/>\n        \n      <\/p>\n<p>Investors who purchased or otherwise acquired DexCom securities during the Class Period may move the Court no later than <strong>December 26, 2025<\/strong>, to be appointed lead plaintiff.<\/p>\n<p align=\"center\">\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=mgbUk2FVEXAPMUwjU5fWvuRAkexAiuJmSGXBmuLuCM4LozFS4-OxemUF2kVY5IVJtoVERsSX974shbrMKUDr5aLDZqPZfo8eyAFg9SSn9QV-cC-tEPWGM6hBcz98C-_1hdrtZuXKRIuDTaSLK7zdip60L7I6mWBuznryI9fkBRtslvzEFPZ6yxbWx2HzVVsc\" rel=\"nofollow\" target=\"_blank\"><br \/>\n          <strong>Why<\/strong><br \/>\n          <strong>\u00a0<\/strong><br \/>\n          <strong>Wolf Haldenstein Adler Freeman &amp; Herz LLP?<\/strong><br \/>\n        <\/a>:<\/p>\n<p align=\"justify\">This illustrious <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-mb1DyUR6WvE662n1S9UrLjh8ulCZK3gB1shNIZqb99cyZhLZ8UmDWUfBWoRLZhsRpA226yhniBUqdg5qVdie3fAnhxPxIe8PXJspttBhkoSE0LnEN-TxGaRGZw8E78t\" rel=\"nofollow\" target=\"_blank\">firm<\/a>, founded in 1888, is steadfast in their pursuit of justice for investors who have suffered financial harm due to these misrepresented statements.\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=w8AdeRRJ15MNGnifa5-NGiOYxHOQ8Upo8xBnA0ozoValk9i624ouDbvyAXsa8xBQlDreCaijuT6Uaak4x_omu6IxRbk4vkDMksAPnJ8fp1mKGvXj70qiPb8y1rrvRRCJ\" rel=\"nofollow\" target=\"_blank\">The law firm<\/a> brings to the fore over 125 years of legal expertise in securities litigation and has a proven track record of protecting the rights of investors.<\/p>\n<p align=\"justify\">We encourage all investors who have been affected or have information that will assist in our investigation, to contact\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=pkXjy8GlMNzVQmiQuizyUhlIaCrbsbyfCPhNPA7I91DvlSae3uS4oHeqSqiht1BMZVjf7fcw0RqEjWIHmNZRsgeQ2FP8ty6sq91Z0Px4fIcCcdYf6FCMzhzNKDeil1eMIt0QtP8DaRqIYTsLUalSp1zuBtrGx413wHSICGvzfrE=\" rel=\"nofollow\" target=\"_blank\">Wolf Haldenstein Adler Freeman &amp; Herz LLP<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>Contact:<\/strong>\n      <\/p>\n<ul type=\"disc\">\n<li style=\"margin-top:5pt;margin-bottom:5pt\">\n          <strong>Phone:<\/strong>\u00a0(800) 575-0735 or (212) 545-4774<\/li>\n<li style=\"margin-top:5pt;margin-bottom:5pt\">\n          <strong>Email:\u00a0<\/strong><br \/>\n          <a href=\"mailto:classmember@whafh.com\" rel=\"nofollow\" target=\"_blank\">classmember@whafh.com<\/a>\n        <\/li>\n<li style=\"margin-top:5pt;margin-bottom:5pt\">\n          <strong>Contact Person:<\/strong>\u00a0<a href=\"mailto:gstone@whafh.com\" rel=\"nofollow\" target=\"_blank\">Gregory Stone, Director of Case and Financial Analysis<\/a><\/li>\n<\/ul>\n<p>\n        <strong>Firm Website:\u00a0<\/strong><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=pkXjy8GlMNzVQmiQuizyUhlIaCrbsbyfCPhNPA7I91DvlSae3uS4oHeqSqiht1BMuJBkcrbZG2xmSmU9TVwVhoH_J_Iu7woaSR8_Wbg4ZHser7B95MK1rmq9dt143XHzzGlhiCAk6Il7seAEdEBzxI-8wYursRmmZf7cCmmQXlk=\" rel=\"nofollow\" target=\"_blank\">Wolf Haldenstein Adler Freeman &amp; Herz LLP<\/a>\n      <\/p>\n<p>This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NjMwMSM3MjM3MDQ1IzIwMTc2NzI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NmUzZjQ5MzEtYTY1ZC00OTYxLTk3MGQtOWIxMTMwMGJjNWJhLTEwMjkyNDItMjAyNS0xMC0zMS1lbg==\/tiny\/Wolf-Haldenstein-Adler-Freeman.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Lead Plaintiff Deadline is December 26, 2025 NEW YORK, Oct. 31, 2025 (GLOBE NEWSWIRE) &#8212; Wolf Haldenstein Adler Freeman &amp; Herz LLP reminds investors that a federal securities class action lawsuit has been filed against DexCom, Inc. (\u201cDexCom\u201d or the \u201cCompany\u201d) (NASDAQ: DXCM) and certain of its officers for alleged violations of federal securities laws. PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION Class Period: July 26, 2024 \u2013 September 17, 2025 (inclusive) The complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements and failed to disclose that: DexCom made material design changes to its G6 and G7 continuous glucose monitoring devices without authorization from the U.S. Food and Drug Administration (FDA) &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Shareholders who lost money in shares of DexCom, Inc. (NASDAQ: DXCM) Should Contact Wolf Haldenstein Immediately&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-903725","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Shareholders who lost money in shares of DexCom, Inc. (NASDAQ: DXCM) Should Contact Wolf Haldenstein Immediately - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Shareholders who lost money in shares of DexCom, Inc. (NASDAQ: DXCM) Should Contact Wolf Haldenstein Immediately - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Lead Plaintiff Deadline is December 26, 2025 NEW YORK, Oct. 31, 2025 (GLOBE NEWSWIRE) &#8212; Wolf Haldenstein Adler Freeman &amp; Herz LLP reminds investors that a federal securities class action lawsuit has been filed against DexCom, Inc. (\u201cDexCom\u201d or the \u201cCompany\u201d) (NASDAQ: DXCM) and certain of its officers for alleged violations of federal securities laws. PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION Class Period: July 26, 2024 \u2013 September 17, 2025 (inclusive) The complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements and failed to disclose that: DexCom made material design changes to its G6 and G7 continuous glucose monitoring devices without authorization from the U.S. Food and Drug Administration (FDA) &hellip; Continue reading &quot;Shareholders who lost money in shares of DexCom, Inc. (NASDAQ: DXCM) Should Contact Wolf Haldenstein Immediately&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-31T16:02:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NjMwMSM3MjM3MDQ1IzIwMTc2NzI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Shareholders who lost money in shares of DexCom, Inc. (NASDAQ: DXCM) Should Contact Wolf Haldenstein Immediately\",\"datePublished\":\"2025-10-31T16:02:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately\\\/\"},\"wordCount\":474,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU2NjMwMSM3MjM3MDQ1IzIwMTc2NzI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately\\\/\",\"name\":\"Shareholders who lost money in shares of DexCom, Inc. (NASDAQ: DXCM) Should Contact Wolf Haldenstein Immediately - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU2NjMwMSM3MjM3MDQ1IzIwMTc2NzI=\",\"datePublished\":\"2025-10-31T16:02:36+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU2NjMwMSM3MjM3MDQ1IzIwMTc2NzI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU2NjMwMSM3MjM3MDQ1IzIwMTc2NzI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Shareholders who lost money in shares of DexCom, Inc. (NASDAQ: DXCM) Should Contact Wolf Haldenstein Immediately\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Shareholders who lost money in shares of DexCom, Inc. (NASDAQ: DXCM) Should Contact Wolf Haldenstein Immediately - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately\/","og_locale":"en_US","og_type":"article","og_title":"Shareholders who lost money in shares of DexCom, Inc. (NASDAQ: DXCM) Should Contact Wolf Haldenstein Immediately - Market Newsdesk","og_description":"Lead Plaintiff Deadline is December 26, 2025 NEW YORK, Oct. 31, 2025 (GLOBE NEWSWIRE) &#8212; Wolf Haldenstein Adler Freeman &amp; Herz LLP reminds investors that a federal securities class action lawsuit has been filed against DexCom, Inc. (\u201cDexCom\u201d or the \u201cCompany\u201d) (NASDAQ: DXCM) and certain of its officers for alleged violations of federal securities laws. PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION Class Period: July 26, 2024 \u2013 September 17, 2025 (inclusive) The complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements and failed to disclose that: DexCom made material design changes to its G6 and G7 continuous glucose monitoring devices without authorization from the U.S. Food and Drug Administration (FDA) &hellip; Continue reading \"Shareholders who lost money in shares of DexCom, Inc. (NASDAQ: DXCM) Should Contact Wolf Haldenstein Immediately\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately\/","og_site_name":"Market Newsdesk","article_published_time":"2025-10-31T16:02:36+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NjMwMSM3MjM3MDQ1IzIwMTc2NzI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Shareholders who lost money in shares of DexCom, Inc. (NASDAQ: DXCM) Should Contact Wolf Haldenstein Immediately","datePublished":"2025-10-31T16:02:36+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately\/"},"wordCount":474,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NjMwMSM3MjM3MDQ1IzIwMTc2NzI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately\/","name":"Shareholders who lost money in shares of DexCom, Inc. (NASDAQ: DXCM) Should Contact Wolf Haldenstein Immediately - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NjMwMSM3MjM3MDQ1IzIwMTc2NzI=","datePublished":"2025-10-31T16:02:36+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NjMwMSM3MjM3MDQ1IzIwMTc2NzI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NjMwMSM3MjM3MDQ1IzIwMTc2NzI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-in-shares-of-dexcom-inc-nasdaq-dxcm-should-contact-wolf-haldenstein-immediately\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Shareholders who lost money in shares of DexCom, Inc. (NASDAQ: DXCM) Should Contact Wolf Haldenstein Immediately"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/903725","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=903725"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/903725\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=903725"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=903725"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=903725"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}